Medical Spending To Treat Hyperlipidemia Up 350% 1996-2003, USA
Main Category: CholesterolAlso Included In: Statins; Cardiovascular / Cardiology; Obesity / Weight Loss / Fitness
Article Date: 14 Feb 2006 - 20:00 PST
| Patient / Public: | ![]() |
4 (2 votes) |
| Healthcare Prof: | ![]() |
3 (2 votes) |
Medical spending to treat hyperlipidemia, a group of conditions that includes high cholesterol and other lipid disorders, increased 350 percent from $4 billion in 1996 to a total of $18 billion in 2003, according to HHS' Agency for Healthcare Research and Quality.
Estimates from AHRQ's Medical Expenditure Panel Survey also show that the number of Americans who were reported to have expenditures to treat hyperlipidemia nearly tripled -- from 7.3 million in 1996 to 21.6 million in 2003. Private health insurers, government programs like Medicare and Medicaid, and patients paid for the health services used to treat hyperlipidemia, primarily prescribed medications and visits to doctor's offices and outpatient clinics.
Statins, one class of prescribed medications used to treat hyperlipidemia, accounted for about 90 percent of the drug expenditures to treat this condition in 2003.
From 1996 to 2003, the proportion of the Medicare population who used at least one statin during the year increased over 250 percent from 8.3 percent to 29.7 percent.
By 2003, the two top-selling drugs in the U.S. (ranked by expenditures) were statins. Total expenditures for Lipitor (Atorvastatin), the top-selling drug, were 7.8 billion, while expenditures for Zocor (Simvastatin) totaled 5.5 billion.
AHRQ data also indicate that, in terms of health care expenditures, heart disease and trauma were the most costly medical conditions in 2003.
MEPS collects information each year from a nationally representative sample of U.S. households about health care use, expenses, access, health status and quality. MEPS is a unique government survey because of the degree of detail in its data, as well as its ability to link data on health services spending and health insurance to demographic, employment, economic, health status, and other characteristics of individuals and families.
This AHRQ News and Numbers is based on online statistics found online in the MEPS Compendia of Tables. To access these data go to meps.ahrq.gov/CompendiumTables/TC_TOC.htm.
http://www.ahrq.gov
Visit our cholesterol section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/37751.php>
APA
http://www.medicalnewstoday.com/releases/37751.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





